Evidence map›Paper›PMID 20876346›Full record

Trial reportMedical decision making : an international journal of the Society for Medical Decision Making

Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.

Gillian W Hooker, Kara-Grace Leventhal, Tiffani DeMarco, Beth N Peshkin, Clinton Finch, Erica Wahl, Jessica Rispoli Joines, Karen Brown, Heiddis Valdimarsdottir, Marc D Schwartz

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical decision making : an international journal of the Society for Medical Decision Making. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 9 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 9 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  3. Decision coaching for people making healthcare decisions.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2017
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Clinical decision support for genetically guided personalized medicine: a systematic review.Journal of the American Medical Informatics Association : JAMIA
    Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Digital health-enabled genomics: Opportunities and challenges.American journal of human genetics · 2022
    Review
  17. Article
  18. Psychometric Properties of the MICRA Questionnaire in Portuguese Individuals Carrying SDHx Mutations.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Gillian W HookerLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Kara-Grace LeventhalLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Tiffani DeMarcoLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Beth N PeshkinLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Clinton FinchLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Erica WahlSection of Genetics and Metabolism, Albany Medical Center, Albany, NY (EW)
Jessica Rispoli JoinesGreenebaum Cancer Center, University of Maryland, Baltimore, MD (JRJ)
Karen BrownDepartment of Genetic and Genomic Sciences, Mount Sinai School of Medicine, New York, NY (KB)
Heiddis ValdimarsdottirDepartment of Oncological Sciences, Mount Sinai School of Medicine, New York, NY (HV)
Marc D SchwartzLombardi Comprehensive Cancer Center, Georgetown University, Washington, DC (GWH, K-GL, TD, BNP, CF, MDS)
Albany Medical Center Hospital · USUniversity of Maryland, Baltimore · USGeorgetown University Medical Center · USIcahn School of Medicine at Mount Sinai · US

Funding

INTERACTIVE DECISION AID FOR BRCA 1/2 MUTATION CARRIERSR01CA082346 · NCI · GEORGETOWN UNIVERSITY · PI SCHWARTZ, MARC D · 1999 to 2003
$2.1M
NCI NIH HHS R01 CA082346NCI NIH HHS R01 CA1846
6 · The paper itself

Abstract

backgroundIncreasingly, women with a strong family history of breast cancer are seeking genetic testing as a starting point to making significant decisions regarding management of their cancer risks. Individuals who are found to be carriers of a BRCA1 or BRCA2 mutation have a substantially elevated risk for breast cancer and are frequently faced with the decision of whether to undergo risk-reducing mastectomy.

objectiveIn order to provide BRCA1/2 carriers with ongoing decision support for breast cancer risk management, a computer-based interactive decision aid was developed and tested against usual care in a randomized controlled trial.

design. Following genetic counseling, 214 female (aged 21-75 years) BRCA1/2 mutation carriers were randomized to usual care (UC; n = 114) or usual care plus decision aid (DA; n = 100) arms. UC participants received no further intervention; DA participants were sent the CD-ROM-based decision aid to view at home.

main outcome measuresThe authors measured general distress, cancer-specific distress, and genetic testing-specific distress at 1-, 6-, and 12-month follow-up time points postrandomization.

resultsLongitudinal analyses revealed a significant longitudinal impact of the DA on cancer-specific distress (B = 5.67, z = 2.81, P = 0.005), which varied over time (DA group by time; B = -2.19, z = -2.47, P = 0.01), and on genetic testing-specific distress (B = 5.55, z = 2.46, P = 0.01), which also varied over time (DA group by time; B = -2.46, z = -2.51, P = 0.01). Individuals randomized to UC reported significantly decreased distress in the month following randomization, whereas individuals randomized to the DA maintained their postdisclosure distress over the short term. By 12 months, the overall decrease in distress between the 2 groups was similar.

conclusionThis report provides new insight into the long-term longitudinal effects of DAs.

Indexed as

Decision Support TechniquesStress, PsychologicalAdaptation, PsychologicalAdultAgedBreast NeoplasmsDecision Making, Computer-AssistedFemaleGenes, BRCA1Genes, BRCA2Genetic CounselingHumansLongitudinal StudiesMammographyMastectomyMiddle Aged

Identifiers

PMID20876346
PMCPMC3935602
OpenAlexW2164406329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.